PROPHASE LABS STOCK FREE

(NASDAQ:PRPH) is 0.29 million shares and it means that shorts have 1.28 day(s) to cover. The stock has a market capitalization of 162.91 million, a PE. Based on these gigs, the overall price performance for the year is 69.23%. The company’s fifty day moving average price is 11.28 and its 200-day moving average price is 8.56.

The stock’s 5-day price performance is 10.15%, and it has moved by -19.51% in 30 days. The stock spiked 5.37% in intraday trading to $11.39 this Friday, 08/05/22, hitting a weekly high. (PRPH) registered a 5.37% upside in the last session and has traded in the green over the past 5 sessions.

PROPHASE LABS STOCK FREE

It's all in the FREE report you can get here. It's a brand new breed of lithium explorer - all you need to do is click and the name and trading symbol is yours. Very few investors know about it yet… so the ground-floor opportunity below $0.30 won't be around much longer. Here's a company - undiscovered by Wall Street and trading below $0.30 per share - which just recently uncovered 8 high-quality targets on unexplored ground, and drills will be turning later this year. Company’s earnings per share (EPS) for the current quarter are expected to be $0.16. The 3 analysts offering 12-month price forecasts for Prophase Labs Inc have a median target of 14.00, with a high estimate of 15.00 and a. 0 analyst(s) has rated the stock Underweight. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. PRPH has a Sell rating from 1 analyst(s) out of 3 analysts who have looked at this stock. That translates to a mean rating of 2.30. (PRPH) received a consensus recommendation of an Overweight from analysts.

The company’s market capitalization is $173.81M, and the average intraday trading volume over the past 10 days was 0.16 million shares, and the average trade volume was 164.88K shares over the past three months. The 52-week high for the PRPH share is $15.25, that puts it down -33.89 from that peak though still a striking 61.55% gain since the share price plummeted to a 52-week low of $4.38. At the end of the trading day, the stock’s price was $11.39, reflecting an intraday gain of 5.37% or $0.58. (NASDAQ:PRPH)’s traded shares were 0.15 million, with the beta value of the company hitting -0.34. All Rights Reserved.During the last session, ProPhase Labs Inc. Sector Health Care Industry Pharmaceuticals Employees 129 Founded 1989 Address 711 Stewart Avenue. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. was founded in 1989 and is headquartered in Garden City, New York. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.

Prophase labs stock